JAK2 and rheumatoid arthritis: suggested that IL-6-induced vascular endothelial growth factor expression and angiogenesis were inhibited through the JAK2/STAT3 pathway in rheumatoid arthritis, providing novel insights into antiangiogenic activity in rheumatoid arthritis (18).